Reversible chemical modifications on DNA and histones are known to significantly impact mammalian gene expression regulation. Prior to our work, no example of reversible chemical modifications on RNA that could affect gene expression had been shown. We previously discovered the first two RNA demethylases: FTO, a protein associated with human fat mass obesity, and ALKBH5, a protein that affects spermatogenesis in a mouse model. These two proteins belong to the AlkB family iron- and 2-ketoglutarate (2-KG)-dependent dioxygenases and catalyze oxidative demethylation of the most prevalent internal modifications of mammalian messenger RNA (mRNA) and other nuclear RNA, N6-methyladenosine (m6A). These studies provided the first demonstration of reversible RNA modification, and stimulated the emergence of a new area of biological studies on RNA modifications in gene expression regulation. In the past funding period, we have demonstrated oncogenic roles of both FTO and ALKBH5 in human cancers. We have also discovered the first tRNA demethylase, ALKBH1, which reverses the N1- methyladenosine (m1A) in tRNA to significantly affect translation initiation and elongation. In the current application, we plan to thoroughly characterize the cytoplasmic versus nuclear RNA demethylation by FTO. Our preliminary studies revealed that RNA substrates of FTO can vary dramatically in different cellular compartments. While FTO is generally regarded as a nuclear protein, it can localize to cytoplasm and mediates functionally significant cytoplasmic RNA demethylation. Previous studies have also uncovered intriguing roles of FTO in UV DNA damage response. Its nuclear demethylation activity may alter the chromatin state and affect recruitment of various factors in damage response. We plan to investigate the extent of nuclear versus cytoplasmic demethylation and understand factors that dictate the cytoplasmic location and demethylation of FTO. These new information will be critical in evaluating small molecule inhibitors that target FTO to suppress tumor progression. In addition to mRNA m6A demethylation, we have recently discovered that ALKBH7, a protein significantly affects mammalian energy homeostasis, is a mitochondrial tRNA demethylase that mediates demethylation of mitochondrial tRNA N2,N2-dimethylguanine (m22G) and affects cellular response to oxidizing agents. We will perform detailed biochemical, structural, and functional characterization of this new tRNA demethylation activity, and reveal its potential impacts on mitochondrial activity.

Public Health Relevance

We have discovered several mammalian RNA demethylases previously. The proposed research will investigate the mechanisms of cytoplasmic versus nuclear RNA demethylation by FTO and a newly discovered mitochondrial tRNA demethylase, and their roles in response to UV DNA damage and ROS exposure.

Agency
National Institute of Health (NIH)
Institute
National Institute of Environmental Health Sciences (NIEHS)
Type
Research Project (R01)
Project #
5R01ES030546-16
Application #
10086097
Study Section
Synthetic and Biological Chemistry A Study Section (SBCA)
Program Officer
Tyson, Frederick L
Project Start
2005-08-01
Project End
2024-01-31
Budget Start
2021-02-01
Budget End
2022-01-31
Support Year
16
Fiscal Year
2021
Total Cost
Indirect Cost
Name
University of Chicago
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
005421136
City
Chicago
State
IL
Country
United States
Zip Code
60637